Status
Conditions
Study type
Funder types
Identifiers
About
The primary purpose of the study is to evaluate effect of Dexilant treatment among GERD participants in the Russian Federation.
Full description
This is an observational, prospective non-interventional study of participants with GERD. This study will evaluate the effect of dexlansoprazole treatment among participants with GERD.
The study will enroll approximately 1500 participants. Due to non-interventional design of the study, the decision about GERD treatment strategy for the participant is taken by attending treating physician. All participants will be enrolled in one observational group: dexlansoprazole.
Prospective data will be collected for a period of 2 months. The frequency of the visits will be assigned by each physician according to their routine practice.
The multi-center trial will be conducted in Russia. The overall duration of study will be approximately 2 months.
Sex
Ages
Volunteers
Inclusion criteria
Male and female participants 18 or older years of age by the time of enrolment.
Confirmed GERD diagnosis (Non-Erosive Reflux Disease (NERD) or Erosive Reflux Diseases (ERD)) on the base of typical clinical features (symptoms), upper endoscopy within last 12 months prior to inclusion and/or GERDq.
Participants diagnosed with GERD less than (<) 3 years prior to study entry, with or without treatment with other GERD medications.
Participants without concomitant gastrointestinal (GI) conditions of the gastrointestinal tract and with concomitant GI conditions of the gastrointestinal tract as well as other organ systems concomitant conditions.
The physician decides to prescribe Dexilant:
Written informed consent, signed before the participation in the study begins.
Exclusion criteria
0 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal